Literature DB >> 15554262

Inhibition of phospholipase Cgamma1 and cancer cell proliferation by lignans and flavans from Machilus thunbergii.

Ji Suk Lee1, Jinwoong Kim, Young Uck Yu, Young Choong Kim.   

Abstract

Thirteen compounds were isolated from the CH2Cl2 fraction of Machilus thunbergii as phospholipase Cgamma1 (PLCgamma1) inhibitors. These compounds were identified as nine lignans, two neolignans, and two flavans by spectroscopic analysis. Of these, 5,7-di-O-methyl-3',4'-methylenated (-)-epicatechin (12) and 5,7,3'-tri-O-methyl (-)-epicatechin (13) have not been reported previously in this plant. In addition, seven compounds, machilin A (1), (-)-sesamin (3), machilin G (5), (+)-galbacin (9), licarin A (10), (-)-acuminatin (11) and compound 12 showed dose-dependent potent inhibitory activities against PLCgamma1 in vitro with IC50 values ranging from 8.8 to 26.0 microM. These lignans, neolignans, and flavans are presented as a new class of PLCgamma1 inhibitors. The brief study of the structure activity relationship of these compounds suggested that the benzene ring with the methylene dioxy group is responsible for the expression of inhibitory activities against PLCgamma1. Moreover, it is suggested that inhibition of PLCgamma1 may be an important mechanism for an antiproliferative effect on the human cancer cells. Therefore, these inhibitors may be utilized as cancer chemotherapeutic and chemopreventive agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554262     DOI: 10.1007/bf02975429

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

1.  Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.

Authors:  Kuzhuvelil B Harikumar; Bokyung Sung; Sheeja T Tharakan; Manoj K Pandey; Beena Joy; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2010-05-11       Impact factor: 5.852

Review 2.  Lignans: a versatile source of anticancer drugs.

Authors:  Minky Mukhija; Bhuwan Chandra Joshi; Partha Sarathi Bairy; Anurag Bhargava; Archana N Sah
Journal:  Beni Suef Univ J Basic Appl Sci       Date:  2022-06-04

3.  Bright Side of Lignin Depolymerization: Toward New Platform Chemicals.

Authors:  Zhuohua Sun; Bálint Fridrich; Alessandra de Santi; Saravanakumar Elangovan; Katalin Barta
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

4.  Sesamin Induces Human Leukemic Cell Apoptosis via Mitochondrial and Endoplasmic Reticulum Stress Pathways.

Authors:  Ratana Banjerdpongchai; Siriporn Yingyurn; Prachya Kongtawelert
Journal:  World J Oncol       Date:  2010-04-30

5.  Metabolomic Profiling and Cytotoxic Tetrahydrofurofuran Lignans Investigations from Premna odorata Blanco.

Authors:  Abeer H Elmaidomy; Rabab Mohammed; Hossam M Hassan; Asmaa I Owis; Mostafa E Rateb; Mohammad A Khanfar; Markus Krischke; Martin J Mueller; Usama Ramadan Abdelmohsen
Journal:  Metabolites       Date:  2019-10-13

6.  In vitro antioxidant and antiproliferative activities of plants of the ethnopharmacopeia from northwest of Mexico.

Authors:  Manuel Jiménez-Estrada; Carlos Velázquez-Contreras; Adriana Garibay-Escobar; Davisela Sierras-Canchola; Ricardo Lapizco-Vázquez; Carolina Ortiz-Sandoval; Armando Burgos-Hernández; Ramón Enrique Robles-Zepeda
Journal:  BMC Complement Altern Med       Date:  2013-01-10       Impact factor: 3.659

7.  Genotoxicity and Cytotoxicity Evaluation of the Neolignan Analogue 2-(4-Nitrophenoxy)-1Phenylethanone and its Protective Effect Against DNA Damage.

Authors:  Alex Lucas Hanusch; Guilherme Roberto de Oliveira; Simone Maria Teixeira de Sabóia-Morais; Rafael Cosme Machado; Murilo Machado Dos Anjos; Lee Chen Chen
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.